Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
7.77
-0.14 (-1.77%)
May 14, 2025, 1:08 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M